about
Prevention of fatal opioid overdoseOpioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysisUpdate in addiction medicine for the generalistSexually transmitted infections among HIV-infected heavy drinkers in St Petersburg, Russia.Methadone dose, take home status, and hospital admission among methadone maintenance patients.Recent drug use, homelessness and increased short-term mortality in HIV-infected persons with alcohol problems.Nondisclosure of HIV infection to sex partners and alcohol's role: a Russian experienceOffice-based management of opioid dependence with buprenorphine: clinical practices and barriersIllicit drugs, alcohol, and addiction in human immunodeficiency virus.Is cannabis use associated with HIV drug and sex risk behaviors among Russian HIV-infected risky drinkers?Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? A patient safety issue.Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis.Fatal and non-fatal overdose after narcology hospital discharge among Russians living with HIV/AIDS who inject drugs.The associations of binge alcohol use with HIV/STI risk and diagnosis among heterosexual African American men.Opioid overdose fatality prevention--reply.Opioid overdose prevention with intranasal naloxone among people who take methadone.Knowledge of and interest in hepatitis C treatment at a methadone clinic.Integration of substance use treatment and medical care: a special issue of JSAT.Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug testsNon-fatal opioid-related overdoses among adolescents in Massachusetts 2012-2014Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdoseAssociation between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysisTouchpoints - Opportunities to predict and prevent opioid overdose: A cohort studyThe Contribution of Prescribed and Illicit Opioids to Fatal Overdoses in Massachusetts, 2013-2015Rurality and differences in pharmacy characteristics and community factors associated with provision of naloxone in the pharmacyStudy protocol for the targeting effective analgesia in clinics for HIV (TEACH) study - a cluster randomized controlled trial and parallel cohort to increase guideline concordant care for long-term opioid therapy among people living with HIVAssociations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine
P50
Q24631270-997D2F94-6658-48CF-BCE0-BAD64AE1AD24Q28397248-51007204-DAEA-4AC7-83D5-726210D7DB5CQ34506003-88F87110-B42E-483D-A444-50227449F149Q34519897-5502E577-EEE4-4D7A-9A99-9C75F76E54FAQ36157367-D1DFCCCB-314F-4A23-B0D9-B8C2E7A9B6DBQ36468227-3F938C6A-8F6F-4B98-871C-DF0BB2B88C36Q36790098-0BCD5332-ABDC-465C-B2DF-7130E884108FQ36841125-702FD834-1179-43E7-AC29-C4DDE58F0381Q36877925-270CD8BE-739A-4CD6-956B-2AFCA2CE0072Q37053843-DC21F7F7-E8FA-4811-AAE2-81453D001C49Q37305173-3EB77918-7AE9-4E62-AEEE-F515DF8F67C2Q37943236-8B2C118A-4090-4959-A25C-192A5D52E501Q39138996-D675F425-3910-4B1C-BCBD-16834896A038Q39867861-EC2F6D12-E56A-45C3-AD55-B1D23F2C4E92Q43553678-CAAAD8D6-295B-4773-AFF9-28B1AA9D37C9Q44336009-D34ABE77-5286-4391-8A36-770E644545DCQ48494486-D96084A0-AA96-4CBC-AA43-EF363165C003Q52301662-17F07C76-BBD5-4A22-81A5-E91406F0DB94Q57069724-3237EBDB-34A2-4DE7-A78D-17839B7891B0Q58555044-7FB771E2-FF07-4893-9F3F-2BE3B0703E2EQ83639955-2B2A40C4-B5C7-4492-9D75-1E014179881FQ89874726-AF2CFDF6-A82D-4157-8894-051E747B3999Q90110148-47AA3890-BC79-4089-BD4E-FC1939729BE9Q90436432-8D7E8749-65DA-4F21-A6B0-4D0272AE6A4AQ91327758-1D4B1B2E-E38F-4B25-94E8-BDE69E702C20Q91860602-811422CA-50AB-4CFE-95D2-9315981F1F7BQ92509319-6DCB00F4-0DB5-4CC0-AA44-22909B5C9DBF
P50
description
researcher ORCID ID = 0000-0002-8158-4882
@en
wetenschapper
@nl
name
Alexander Y Walley
@ast
Alexander Y Walley
@en
Alexander Y Walley
@nl
type
label
Alexander Y Walley
@ast
Alexander Y Walley
@en
Alexander Y Walley
@nl
prefLabel
Alexander Y Walley
@ast
Alexander Y Walley
@en
Alexander Y Walley
@nl
P106
P31
P496
0000-0002-8158-4882